Remarkably, our results on the role of COMMD1 in cisplatin sensitivity are in contradiction with prior data that demonstrated that reduced levels of COMMD1 in a breast cancer cell line [3] and a hepatoma cell line [21] lead to increased cisplatin sensitivity. This evidence concerns the gene COMMD1 and breast cancer.